Possible analgesic effect of vigabatrin in animal experimental chronic neuropathic pain

Arquivos de Neuro-Psiquiatria

Volumn 57, Issue 4, 1999, Pages 916-920

  Alves, Nilza Dutra ^a   De Castro Costa, Carlos M ^b   De Carvalho, Alba M ^b   Santos, Franklin J C ^b   Silveira, Delano G ^b  

^a FEDERAL UNIVERSITY OF CEARÁ   (Brazil)

^b NONE

Author keywords

Analgesia; Experimental; Neuropathic pain; Scratching behavior; Thermal tests; Vigabatrin; Wistar rats

Indexed keywords

ANTICONVULSIVE AGENT; CARBAMAZEPINE; NALOXONE; PHENYTOIN; VALPROIC ACID; VIGABATRIN;

ANALGESIC ACTIVITY; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHRONIC PAIN; CONTROLLED STUDY; DRUG MECHANISM; FOCAL EPILEPSY; GABAERGIC SYSTEM; INTRAPERITONEAL DRUG ADMINISTRATION; NEURALGIA; NOCICEPTIVE STIMULATION; NONHUMAN; ORAL DRUG ADMINISTRATION; PERIPHERAL NEUROPATHY; RAT; SCIATIC NERVE;

EID: 0032734824     PISSN: 0004282X     EISSN: None     Source Type: Journal    
DOI: 10.1590/S0004-282X1999000600003     Document Type: Article

References (30)

1. Withrington RH, Wynn Parry CB. The management of painful peripheral nerve disorders. J Hand Surg 1984;9B:24-28.
2. Davies HTO, Crombie IK, Londoale M, et al. Consensus and contention in the treatment of chronic nerve-damage pain. Pain 1991;47:191-196.
3. Blom S. Trigeminal neuralgia: its treatment with a new anticonvulsive drug (G32883). Lancet 1962;1:839-840.
4. Thompson T. Carbamazepine therapy in trigeminal neuralgia. Arch Neurol 1980;37: 699-703.
5. Rull JA, Quibrera R, Gonzales-Millan H, et al. Symptomatic treatment of peripheral diabetic neuropathy with carbamazepine (Tegretol): a double-blind, crossover trial. Diabetologia 1969;5:215-218.
6. Moura FEA. Estudo comportamental-farmacológico de ratos portadores de mononeuropatia ciática compressiva crônica: um modelo animal de dor neuropática crônica. Tese de Mestrado em Farmacologia. Faculdade de Medicina, Universidade Federal do Ceará. Fortaleza, 1995.
7. Chapman V, Suzuki R, Chamarette HLC, et al. Effects of systemic carbamazepine and gabapentin on spinal neuronal responses in spinal nerve ligated rats. Pain 1998; 75:261-272.
8. Shimoyama M, Shimoyama N, Inturrisi CE, et al. Gabapentin enhances the antinociceptive effects of spinal morphine in the rats tail flick test. Pain 1997;72:375-382.
9. Nakamura-Craig M, Follenfant RL. Effect of lamotrigine in the acute and chronic hyperalgesia in rats with streptozotocin-induced diabetes. Pain 1995;63:33-37.
10. Zakrzewska JM, Chaudhry Z, Nurmikko TJ, et al. Lamotrigine (Lamictal) in refractory trigeminal neuralgia: results from a double-blind placebo controlled crossover trial. Pain 1997;73:223-230.
11. Grant SM, Heel RC. Vigabatrin: a review. Drugs 1991;41:889-926.
12. Bennett GJ, Xie YK. A peripheral mononeuropathy in rats that produces disorders of pain sensation like those seen in Man. Pain 1988;33:87-107.
13. Seltzer Z, Dubner R, Shir Y. A novel behavioral model of neuropathic pain disorders produced in rats by partial sciatic nerve injury. Pain 1990;43:205-218.
14. De Castro-Costa CM, De Sutter P, Gybels J, et al. Adjuvant induced arthritis in rats: a possible animal model of chronic pain. Pain 1981;10:173-185.
15. Kupers R, Nuytten D, De Castro-Costa CM, et al. A time course analysis of the spontaneous and evoked behaviour in a rat model of neuropathic pain. Pain 1992;50: 101-111.
16. Attal N, Jazat F, Kayser V et al. Further evidences for pain-related behaviours in a model of unilateral peripheral mononeuropathy. Pain 1990;41:235-251.
17. IASP, Committee for Research and Ethical Issues. Ethical standards for investigation of experimental pain in animal. Pain 1983;16:109-110.
18. Shorvon SD, Espir MLE, Steiner TJ, et al. Is there a place for placebo controlled trials of antiepiletic drug? Br Med J 1985;291:1328-1329.
19. Gram L, Larsson OM, Johnsen AH, et al. Effects of valproate, vigabatrin and aminooxyacetic acid on release of endogenous and exogenous GABA from cultured neurons. Epilepsy Res 1988:2:87-95.
20. Bernasconi R, Klein M, Martin P, et al. Gamma-vinyl-GABA: comparison of neurochemical and anticonvulsant effects in mice. J Neural Transm 1988;72:213-233.
21. Miller JW, McKeon AC, Ferrendelli JA. Functional anatomy of pentylenetetrazol and electroshock seizures in the rat brainstem. Ann Neurol 1987;22:615-621.
22. Toussi H, Schatz RA, Waszezak BL. Suppression of methionine sulfoximine seizures by intranigral Y-vinyl-GABA injection. Eur J Pharmacol 1987;137:261-264.
23. Liu Z, Seiler N, Marescaux C, et al. Potentiation of Y-VINYL-GABA (vigabatrin) effects by glycine. Eur J Pharmacol 1990;182:109-115.
24. DeFeudis FV. GABA-ergic analgesia: an overview. Drugs Today 1986;22:563-573.
25. Fromm GH, Terrence CF, Chattha AS. Treatment of face pain with Baclofen. Trans Am Neurol Assoc 1980;105:486-488.
26. Martins PI, Ferro JM. Atypical facial pain, ectasia of the basilar artery and baclofen: a case report. Headache 1989;29:581-583.
27. Anghinab R, Oliveira ASB, Gabbai AA. Effect of baclofen on pain in diabetic neuropathy. Muscle Nerve 1994;17:958-959.
28. Herman RM, D'Luzansky SC, Ippolifo R. Intrathecal baclofen suppresses central pain in patients with spinal lesions. Clin J Pain 1992;8:338-345.
29. Santos TJT. Analgesic effect of baclofen (bela-p-chlorofenil-GABA) in experimental neuropathic pain (Abstr). Arq Neuropsiquiatr 1996;54:712-713.
30. Porter RJ, Meldrum BS. Medicamentos antiepilépticos. In Katzunged BJ (ed). Farmacologia básica e clínica. 5Ed., Rio de Janeiro: Guanabara Koogan, 1992:248-261.